Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05127551
NA
Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite Vs. Competitor
Sponsor: Glaukos Corporation
View on ClinicalTrials.gov
Summary
A study of the iStent Infinite product in the treatment of open-angle glaucoma vs competitor
Official title: A Prospective, Randomized, Controlled, Comparitive Multicenter Clinical Study of Glaukos® Trabecular Micro-Bypass System Model iS3 Infinite® vs Competitor in Adult Subjects With Primary Open-Angle Glaucoma (POAG)
Key Details
Gender
All
Age Range
35 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
179
Start Date
2021-11-27
Completion Date
2025-02-28
Last Updated
2024-08-15
Healthy Volunteers
No
Conditions
Interventions
DEVICE
iStent Infinite
Implantation of the iStent Infinite
DEVICE
Competitor Device
Implantation of competitor device
Locations (1)
Glaukos Investigator Sites
Montreal, Qubec, Canada